By expanding our investigation to disease-relevant tau oligomers,  derived from brain tissues of different tauopathies, and the effects of curcumin derivatives in animal models of tauopathies, will further increase our understanding of the therapeutic potential and the mechanism of action of curcumin derivatives. This evidence concerns the gene MAPT and tauopathy.